Prescribing information available here
Correct inhaler use is the cornerstone of successful asthma and COPD treatment. Most patients learn to use Easyhaler® correctly in less than 5 minutes, thus also saving physicians’ valuable time.1-4
Date of preparation: October 2022 / EASYH-2724
References
- Gálffy G, Mezei G, Nemeth G et al. Inhaler Competence and Patient Satisfaction with Easyhaler®: Results of Two Real-Life Multicentre Studies in Asthma and COPD. Drugs R D 2013 Sep;13(3):215–22.
- Tamasi L, Szilasi M, Gálffy G. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler®, for Patients with Poorly Controlled Obstructive Airway Disease: a Real-World Study of Patient-Reported Outcomes. Adv Ther. 2018;35:1140–1152.
- Syk J, Vinge I, Sörberg M, et al. A multicenter, observational, prospective study of the effectiveness of switching from budesonide/formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®. Adv Ther. 2019;36(7):1756–1769.
- Gálffy G, Szilasi M, Tamási L. Effectiveness and patient satisfaction with budesonide/formoterol Easyhaler® among patients with asthma or COPD switching from previous treatment: a real-world study of patient-reported outcomes. Pulm Ther. 2019;5:165-177.
DATE OF PREPARATION: MAY 2023/EASYH-688(10)
FULL PRESCRIBING INFORMATION AVAILABLE HERE
For more information about Orion and Sustainability click here
